Treatment of allergic bronchopulmonary aspergillosis with biologics. [PDF]
Asano K +4 more
europepmc +1 more source
Clinical Characteristics of Difficult-To-Treat Allergic Bronchopulmonary Aspergillosis and Its Prediction Score. [PDF]
Tanaka J +19 more
europepmc +1 more source
Serum periostin and carcinoembryonic antigen for diagnosing and assessing response in allergic bronchopulmonary aspergillosis. [PDF]
Sah R +10 more
europepmc +1 more source
Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management. [PDF]
Huang X, Zheng Y, Jin X, Zheng Q, Pan K.
europepmc +1 more source
Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis. [PDF]
He Q, Li M, Cao J, Zhang M, Feng C.
europepmc +1 more source
Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022. [PDF]
Benedict K, Gold JAW, Toda M, Hsu J.
europepmc +1 more source
Predicting Mortality in Intensive Care Unit Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) Using an Interpretable Machine Learning Model: A Retrospective Cohort Study. [PDF]
Zhang J +5 more
europepmc +1 more source
Allergic bronchopulmonary aspergillosis [PDF]
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated lung disease which occurs predominantly in patients with asthma, and is caused by hypersensitivity to colonized Aspergillus fumigatus. It is a chronic, relapsing disorder which can clinically range from mild asthma to fibrotic lung disease.
A -B Tonnel
exaly +5 more sources

